Available Stat

No

Performing Lab

Medical Genomics - Molecular Diagnostics

Performed

Run 1x per week as needed, Monday or Wednesday, day shift only

Methodology

PCR followed by DNA sequencing

Reported

7-10 days

Additional Information

DNA sequencing of the beta-globin gene is suggested only when testing with the allele-specific probes for beta thalassemia is negative and when Hb A2 levels are elevated or a variant hemoglobin identified by HPLC testing cannot be confirmed by conventional methods. It is also possible that the presence of iron deficiency may confound the Hb A2 levels, and thus DNA sequencing may be warranted if the beta thalassemia mutations test is negative. SEE NOTES: On Thalassemia Mutations Test.

If a mutation is detected it is recommended that the patient seek genetic counseling.

Note: This test was developed and its performance characteristics determined by the Clinical Laboratories at the Medical Center at UC San Francisco. It has not been cleared or approved by the U.S. Food and Drug Administration.

Reflex Testing

An interpretation of this test by a laboratory physician will automatically be performed and billed for separately.

Synonyms

  • PCR

Sample Type

EDTA whole blood, Amniotic fluid, CVS

Collect

Lavender top

Amount to Collect

3 mL blood

Preferred Volume

Blood: 3 mL
Amniotic Fluid: 5 mL
CVS: 10 mg

Minimum Volume

0.5 mL blood

Remarks

Do not collect sample in heparin. Keep sample refrigerated for overnight or longer storage.

Test Code

BGSQ

Test Group

Thalassemia

Performing Lab

Medical Genomics - Molecular Diagnostics

Specimen Preparation

Do not centrifuge the specimen. Store at room temperature. Refrigerated samples are acceptable.

Preferred Volume

Blood: 3 mL
Amniotic Fluid: 5 mL
CVS: 10 mg

Minimum Volume

0.5 mL blood

Reference Interval

Negative

Additional Information

DNA sequencing of the beta-globin gene is suggested only when testing with the allele-specific probes for beta thalassemia is negative and when Hb A2 levels are elevated or a variant hemoglobin identified by HPLC testing cannot be confirmed by conventional methods. It is also possible that the presence of iron deficiency may confound the Hb A2 levels, and thus DNA sequencing may be warranted if the beta thalassemia mutations test is negative. SEE NOTES: On Thalassemia Mutations Test.

If a mutation is detected it is recommended that the patient seek genetic counseling.

Note: This test was developed and its performance characteristics determined by the Clinical Laboratories at the Medical Center at UC San Francisco. It has not been cleared or approved by the U.S. Food and Drug Administration.

CPT Codes

81364

LDT or Modified FDA

Yes

LOINC Codes

21689-5

Available Stat

No

Test Code

BGSQ

Test Group

Thalassemia

Performing Lab

Medical Genomics - Molecular Diagnostics

Performed

Run 1x per week as needed, Monday or Wednesday, day shift only

Methodology

PCR followed by DNA sequencing

Remarks

Do not collect sample in heparin. Keep sample refrigerated for overnight or longer storage.

Collect

Lavender top

Amount to Collect

3 mL blood

Sample Type

EDTA whole blood, Amniotic fluid, CVS

Preferred Volume

Blood: 3 mL
Amniotic Fluid: 5 mL
CVS: 10 mg

Minimum Volume

0.5 mL blood

Specimen Preparation

Do not centrifuge the specimen. Store at room temperature. Refrigerated samples are acceptable.

Reference Interval

Negative

Synonyms

  • PCR

Reported

7-10 days

Reflex Testing

An interpretation of this test by a laboratory physician will automatically be performed and billed for separately.

Additional Information

DNA sequencing of the beta-globin gene is suggested only when testing with the allele-specific probes for beta thalassemia is negative and when Hb A2 levels are elevated or a variant hemoglobin identified by HPLC testing cannot be confirmed by conventional methods. It is also possible that the presence of iron deficiency may confound the Hb A2 levels, and thus DNA sequencing may be warranted if the beta thalassemia mutations test is negative. SEE NOTES: On Thalassemia Mutations Test.

If a mutation is detected it is recommended that the patient seek genetic counseling.

Note: This test was developed and its performance characteristics determined by the Clinical Laboratories at the Medical Center at UC San Francisco. It has not been cleared or approved by the U.S. Food and Drug Administration.

CPT Codes

81364

LDT or Modified FDA

Yes

LOINC Codes

21689-5
Ordering

Available Stat

No

Performing Lab

Medical Genomics - Molecular Diagnostics

Performed

Run 1x per week as needed, Monday or Wednesday, day shift only

Methodology

PCR followed by DNA sequencing

Reported

7-10 days

Additional Information

DNA sequencing of the beta-globin gene is suggested only when testing with the allele-specific probes for beta thalassemia is negative and when Hb A2 levels are elevated or a variant hemoglobin identified by HPLC testing cannot be confirmed by conventional methods. It is also possible that the presence of iron deficiency may confound the Hb A2 levels, and thus DNA sequencing may be warranted if the beta thalassemia mutations test is negative. SEE NOTES: On Thalassemia Mutations Test.

If a mutation is detected it is recommended that the patient seek genetic counseling.

Note: This test was developed and its performance characteristics determined by the Clinical Laboratories at the Medical Center at UC San Francisco. It has not been cleared or approved by the U.S. Food and Drug Administration.

Reflex Testing

An interpretation of this test by a laboratory physician will automatically be performed and billed for separately.

Synonyms

  • PCR
Collection

Sample Type

EDTA whole blood, Amniotic fluid, CVS

Collect

Lavender top

Amount to Collect

3 mL blood

Preferred Volume

Blood: 3 mL
Amniotic Fluid: 5 mL
CVS: 10 mg

Minimum Volume

0.5 mL blood

Remarks

Do not collect sample in heparin. Keep sample refrigerated for overnight or longer storage.
Processing

Test Code

BGSQ

Test Group

Thalassemia

Performing Lab

Medical Genomics - Molecular Diagnostics

Specimen Preparation

Do not centrifuge the specimen. Store at room temperature. Refrigerated samples are acceptable.

Preferred Volume

Blood: 3 mL
Amniotic Fluid: 5 mL
CVS: 10 mg

Minimum Volume

0.5 mL blood
Result Interpretation

Reference Interval

Negative

Additional Information

DNA sequencing of the beta-globin gene is suggested only when testing with the allele-specific probes for beta thalassemia is negative and when Hb A2 levels are elevated or a variant hemoglobin identified by HPLC testing cannot be confirmed by conventional methods. It is also possible that the presence of iron deficiency may confound the Hb A2 levels, and thus DNA sequencing may be warranted if the beta thalassemia mutations test is negative. SEE NOTES: On Thalassemia Mutations Test.

If a mutation is detected it is recommended that the patient seek genetic counseling.

Note: This test was developed and its performance characteristics determined by the Clinical Laboratories at the Medical Center at UC San Francisco. It has not been cleared or approved by the U.S. Food and Drug Administration.
Administrative

CPT Codes

81364

LDT or Modified FDA

Yes

LOINC Codes

21689-5
Complete View

Available Stat

No

Test Code

BGSQ

Test Group

Thalassemia

Performing Lab

Medical Genomics - Molecular Diagnostics

Performed

Run 1x per week as needed, Monday or Wednesday, day shift only

Methodology

PCR followed by DNA sequencing

Remarks

Do not collect sample in heparin. Keep sample refrigerated for overnight or longer storage.

Collect

Lavender top

Amount to Collect

3 mL blood

Sample Type

EDTA whole blood, Amniotic fluid, CVS

Preferred Volume

Blood: 3 mL
Amniotic Fluid: 5 mL
CVS: 10 mg

Minimum Volume

0.5 mL blood

Specimen Preparation

Do not centrifuge the specimen. Store at room temperature. Refrigerated samples are acceptable.

Reference Interval

Negative

Synonyms

  • PCR

Reported

7-10 days

Reflex Testing

An interpretation of this test by a laboratory physician will automatically be performed and billed for separately.

Additional Information

DNA sequencing of the beta-globin gene is suggested only when testing with the allele-specific probes for beta thalassemia is negative and when Hb A2 levels are elevated or a variant hemoglobin identified by HPLC testing cannot be confirmed by conventional methods. It is also possible that the presence of iron deficiency may confound the Hb A2 levels, and thus DNA sequencing may be warranted if the beta thalassemia mutations test is negative. SEE NOTES: On Thalassemia Mutations Test.

If a mutation is detected it is recommended that the patient seek genetic counseling.

Note: This test was developed and its performance characteristics determined by the Clinical Laboratories at the Medical Center at UC San Francisco. It has not been cleared or approved by the U.S. Food and Drug Administration.

CPT Codes

81364

LDT or Modified FDA

Yes

LOINC Codes

21689-5